company

DAHRT BIOCARE AS

1352 KOLSÃ…S

Return on Equity
−71,72 %
Current Ratio
5,08
Debt-to-Equity Ratio
0,89
Key figures (NOK)2022
Revenue101 000
Net Income−71 000
Total Assets212 000
Total Equity99 000
Income (NOK)2022
Revenue101 000
Expenditure167 000
Operating Profit−67 000
Financial Income0
Financial Costs4 000
Financial Balance−4 000
Earnings Before Tax−71 000
Tax0
Net Income−71 000
Balance (NOK)2022
Total Fixed Assets86 000
Total Current Assets127 000
Total Assets212 000
Total Retained Equity−119 000
Total Equity99 000
Total Long-Term Debt88 000
Total Current Debt25 000
Total Equity and Debt212 000
Cash flow (NOK)2022
Sales Income29 000
Other Income72 000
Revenue101 000
Cost of Goods Sold8 000
Salary Costs0
Depreciation45 000
Impairment0
Expenditure167 000
Operating Profit−67 000
Financial Income0
Financial Costs4 000
Financial Balance−4 000
Dividends0
Net Income−71 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets86 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets86 000
Stock118 000
Total Investments0
Cash, Bank8 000
Total Current Assets127 000
Total Assets212 000
Total Equity99 000
Short-Term Group Debt0
Total Long-Term Debt88 000
Creditors11 000
Unpaid Taxes0
Dividends0
Other Current Debt14 000
Total Current Debt25 000
Total Equity and Debt212 000
Financial indicators2022
Return on Equity−71,72 %
Debt-to-Equity Ratio0,89
Operating Profit Margin−66,34 %
Current Ratio5,08
Quick Ratio−1,37
Equity Ratio0,47
Gross Profit Margin92,08 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English